Absci Corp (ABSI)

Jan 02, 2026

Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 02, 2026

Dec 31, 2025

Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment - Finviz

Dec 31, 2025

Dec 30, 2025

Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial - Finviz

Dec 30, 2025

Dec 29, 2025

Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN

Dec 29, 2025

Dec 29, 2025

10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey

Dec 29, 2025

Dec 27, 2025

Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz

Dec 27, 2025

Dec 23, 2025

Absci (NASDAQ:ABSI) Trading Down 4.2%Here's What Happened - MarketBeat

Dec 23, 2025

Dec 22, 2025

Absci (NASDAQ:ABSI) Trading Up 11.1%Time to Buy? - MarketBeat

Dec 22, 2025

Dec 20, 2025

Why analysts remain bullish on Absci Corporation stockWeekly Profit Analysis & Smart Investment Allocation Tips - Улправда

Dec 20, 2025

Dec 20, 2025

Will Absci Corporation stock recover faster than peersMarket Risk Summary & Reliable Entry Point Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

What technical charts say about Absci Corporation stock2025 Pullback Review & Weekly Chart Analysis and Trade Guides - Улправда

Dec 20, 2025

Dec 19, 2025

Is Absci Corporation stock a defensive play in 2025CPI Data & Risk Controlled Stock Pick Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Will Absci Corporation stock keep outperforming rivalsPortfolio Update Summary & Weekly Sector Rotation Insights - Улправда

Dec 19, 2025

Dec 18, 2025

How resilient is Absci Corporation stock in market downturns2025 Retail Activity & Step-by-Step Trade Execution Guides - Улправда

Dec 18, 2025

Dec 18, 2025

ABSI Stock: HC Wainwright & Co. Raises Price Target to $8.00 | A - GuruFocus

Dec 18, 2025

Dec 18, 2025

Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside - Insider Monkey

Dec 18, 2025

Dec 17, 2025

H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $8 - 富途牛牛

Dec 17, 2025

Dec 17, 2025

14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey

Dec 17, 2025

Dec 17, 2025

Will ABS-201 From Absci Transform The Future Of Hair Regeneration? - RTTNews

Dec 17, 2025

Dec 16, 2025

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 16, 2025

Dec 12, 2025

Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Dec 12, 2025

Dec 12, 2025

Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat

Dec 12, 2025

Dec 12, 2025

Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛

Dec 12, 2025

Dec 12, 2025

Absci’s ABS-201 stimulates human hair follicle growth ex vivo - BioWorld MedTech

Dec 12, 2025

Dec 11, 2025

Independent Director of Absci Picks Up 454% More Stock - Yahoo Finance

Dec 11, 2025

Dec 11, 2025

Absci, former US soccer player Donovan announce partnership - MSN

Dec 11, 2025

Dec 11, 2025

Absci’s ABS-201 antibody shows promise for hair regrowth treatment - Investing.com

Dec 11, 2025

Dec 11, 2025

Absci’s ABS-201 antibody shows promise for hair regrowth treatment By Investing.com - Investing.com Canada

Dec 11, 2025

Dec 11, 2025

Absci Reports New Human Ex Vivo Data Demonstrating That - GlobeNewswire

Dec 11, 2025

Dec 10, 2025

Is Absci Poised for a Surge? - StocksToTrade

Dec 10, 2025

Dec 10, 2025

Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat

Dec 10, 2025

Dec 10, 2025

Absci, former U.S. soccer player Donovan announce partnership - TipRanks

Dec 10, 2025

Dec 10, 2025

Absci Corporation Partners with Landon Donovan to Address Androgenetic Alopecia and Advance Therapeutic Innovations - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - GlobeNewswire

Dec 10, 2025

Dec 10, 2025

Absci (NASDAQ:ABSI) Transforms Biotechnology With AI Integration - Kalkine Media

Dec 10, 2025

Dec 09, 2025

Absci Corp Director Frans Van Houten Acquires 40,000 Shares - TradingView — Track All Markets

Dec 09, 2025

Dec 09, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Dec 09, 2025

Dec 09, 2025

Dir Van Houten Buys 40,000 ($148.8K) Of AbSci Corp [ABSI] - TradingView — Track All Markets

Dec 09, 2025

Dec 05, 2025

Is Absci (ABSI) Using ABS-201 To Quietly Prove The Value Of Its AI Drug Engine? - simplywall.st

Dec 05, 2025

Dec 05, 2025

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study - The Globe and Mail

Dec 05, 2025

Dec 05, 2025

Absci (NASDAQ:ABSI) Stock Price Up 10.8%Still a Buy? - MarketBeat

Dec 05, 2025

Dec 05, 2025

Absci doses first volunteers in phase 1/2a trial of hair loss antibody - Investing.com Nigeria

Dec 05, 2025

Dec 04, 2025

Absci doses first volunteers in phase 1/2a trial of hair loss antibody By Investing.com - Investing.com South Africa

Dec 04, 2025

Dec 04, 2025

Absci Stock’s Financial Prospects: An In-Depth Analysis - StocksToTrade

Dec 04, 2025

Dec 04, 2025

JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛

Dec 04, 2025

Dec 04, 2025

Assessing Absci (ABSI) Valuation After First Volunteers Dosed in ABS-201 HeadLINE Trial - simplywall.st

Dec 04, 2025

Dec 04, 2025

Absci Corp. Strives for New Horizons Amid Financial Adjustments - timothysykes.com

Dec 04, 2025

Dec 04, 2025

Absci announces first participants dosed in Phase 1/2a HEADLINE trial - TipRanks

Dec 04, 2025

Dec 04, 2025

Absci (ABSI): Assessing Valuation as AI‑Designed Hair Loss Drug Enters First Phase 1/2a Trial - Yahoo Finance

Dec 04, 2025